A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Trial Identifier: F506-CL-0405
Sponsor: Astellas Pharma China Inc.
Start Date: January 2022
Primary Completion Date: March 2024
Study Completion Date: March 2024
Condition: Liver Transplants; Kidney Transplants

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China Beijing, China
China Guangzhou, China
China Shanghai, China
China Wuhan, China